NECTAR LIFESCIENCES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Nectar Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.97₹ 0.71
As on Sep 11, 2025, 4:01 PM IST
Nectar Lifesciences Price Performance
Today's LowToday's High
₹14.11₹15.01
₹15.01
52 Weeks' Low52 Weeks' High
₹13.25₹56.39
₹15.01
Open Price
₹14.35
Prev. Close
₹14.30
Volume
66,134
Over the last 5 years, the share price of Nectar Lifesciences has declined 6.32% CAGR. Over the past year, the corresponding return has been -71.70%.
Nectar Lifesciences’s current P/E of -1.87x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Nectar Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Nectar Lifesciences | 2.18 | 1.97 | -38.23 | -43.10 | -71.70 | -14.84 | -6.32 |
| Sun Pharmaceutical Industries | 1.71 | -0.20 | -4.85 | -2.79 | -12.84 | 21.96 | 26.07 |
| Divi's Laboratories | -1.82 | 0.59 | -10.34 | 8.70 | 10.77 | 17.89 | 13.85 |
| Cipla | -1.05 | 3.83 | 2.57 | 7.94 | -4.09 | 13.61 | 16.56 |
| Torrent Pharmaceuticals | -0.59 | -1.06 | 11.52 | 16.85 | 4.03 | 33.36 | 20.31 |
| Dr. Reddy's Laboratories | 3.93 | 6.85 | -3.54 | 16.65 | -1.48 | 15.18 | 8.16 |
| Mankind Pharma | 1.32 | 6.71 | 9.33 | 17.63 | 6.84 | 22.22 | 12.79 |
| Zydus Lifesciences | 3.16 | 9.26 | 6.67 | 16.01 | -6.13 | 40.48 | 23.06 |
| Lupin | 2.61 | 2.25 | -1.85 | 0.69 | -9.91 | 43.63 | 15.52 |
| Abbott India | -4.03 | -6.37 | -2.29 | 1.29 | 4.76 | 19.46 | 12.93 |
| Alkem Laboratories | 1.67 | 11.36 | 10.35 | 12.92 | -14.03 | 18.95 | 13.22 |
| Aurobindo Pharma | 7.19 | 5.40 | -4.35 | 1.70 | -26.38 | 26.29 | 6.69 |
| Glenmark Pharmaceuticals | 6.54 | 3.55 | 29.63 | 51.43 | 22.75 | 75.86 | 34.32 |
| Biocon | 1.93 | 6.36 | 2.68 | 10.59 | -5.60 | 6.23 | -3.41 |
| GlaxoSmithKline Pharmaceuticals | 0.63 | 6.33 | -15.41 | 7.64 | 0.11 | 26.22 | 11.31 |
| Laurus Labs | 2.70 | 7.90 | 32.55 | 56.26 | 77.12 | 17.94 | 28.95 |
| Anthem Biosciences | -2.73 | 8.94 | 12.41 | 12.41 | 12.41 | 3.98 | 2.37 |
| Cohance Lifesciences | 10.87 | 6.03 | -0.50 | -13.73 | -16.31 | 27.94 | 23.52 |
| Ipca Laboratories | -2.11 | -2.04 | -5.71 | 1.51 | -8.73 | 14.40 | 5.38 |
| Gland Pharma | 4.15 | 1.51 | 16.89 | 22.12 | 4.01 | -5.96 | 1.55 |
Over the last one year, Nectar Lifesciences has declined 71.70% compared to peers like Sun Pharmaceutical Industries (-12.84%), Divi's Laboratories (10.77%), Cipla (-4.09%). From a 5 year perspective, Nectar Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (26.07%) and Divi's Laboratories (13.85%).
Nectar Lifesciences Financials
Nectar Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 14.46 | 14.34 |
| 10 | 14.83 | 14.52 |
| 20 | 14.74 | 14.9 |
| 50 | 17.28 | 16.75 |
| 100 | 20.28 | 19.77 |
| 200 | 26.66 | 24.02 |
Nectar Lifesciences Share Holding Pattern
In the latest quarter, Nectar Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 0.19%, FII holding fell to 0.82%, and public shareholding moved up to 54.45% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Nectar Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 02, 2025, 4:51 PM IST | Nectar Lifesciences - Letter Sent To Members |
| Aug 27, 2025, 7:14 PM IST | Nectar Lifesciences - Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations A |
| Aug 26, 2025, 9:19 PM IST | Nectar Lifesciences - Notice Of The 30Th Annual General Meeting ("AGM") For The Financial Year 2024-25. |
| Aug 26, 2025, 6:00 AM IST | Nectar Lifesciences - Reg. 34 (1) Annual Report. |
| Aug 26, 2025, 5:42 AM IST | Nectar Lifesciences - Notice Of The 30Th Annual General Meeting ("AGM") For The Financial Year 2024-25. |
About Nectar Lifesciences
Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1673.07 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressVillage Saidpura, Tehsil Derabassi, Mohali Punjab 140507
- Contact
Management
- Mr. Sanjiv GoyalChairman & Managing Director
- Mr. Puneet SudDirector - Operations
- Dr. Indu Pal KaurIndependent Director
- Mr. Ajay SwaroopIndependent Director
- Dr. Rupinder TewariIndependent Director
- Dr. Kuldip Kumar BhasinIndependent Director
- Ms. Meena VermaNominee Director
FAQs on Nectar Lifesciences Share Price
What is the share price of Nectar Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Nectar Lifesciences is ₹15.01 as on Sep 11, 2025.
What kind of stock is Nectar Lifesciences?
The Nectar Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Nectar Lifesciences?
The market cap of Nectar Lifesciences is ₹336.62 Cr as on Sep 11, 2025.
What are today's High and Low prices of Nectar Lifesciences?
Today’s highest and lowest price of Nectar Lifesciences are ₹15.01 and ₹14.11.
What are the 52 Week High and 52 Week Low of Nectar Lifesciences?
The 52-week high/low is the highest and lowest price at which Nectar Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Nectar Lifesciences is ₹56.39 and 52-week low of Nectar Lifesciences is ₹13.25 as on Sep 11, 2025.
How has the Nectar Lifesciences performed historically in terms of returns?
The Nectar Lifesciences has shown returns of 4.97% over the past day, 1.97% for the past month, -38.23% over 3 months, -71.7% over 1 year, -14.84% across 3 years, and -6.32% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Nectar Lifesciences?
P/E ratio of and PB ratio of Nectar Lifesciences are -1.87 and 0.31 on Sep 11, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data